ACAD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ACADIA Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 25.5 USD -2.75% Market Closed

Market Cap: $4.4B

	ACADIA Pharmaceuticals Inc NASDAQ:ACAD	US
	Stewart Information Services Corp NYSE:STC	US
F	Fresh Del Monte Produce Inc F:FDM	US
N	NIO Inc BCBA:NIO	CN
B	Buckle Inc SWB:BK2	US

Profitability Summary

ACADIA Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

98% > 92%

Low Operating Margin

10%

Strong 3Y Average Operating Margin

33%

Operating Margin is Increasing

-23% > 10%

Exceptional Net Margin

36%

Strong 3Y Average Net Margin

47%

Net Margin is Increasing

-20% > 36%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

-30% > 1%

Exceptional ROE

40%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

88%

ROIC is Increasing

-65% > 834%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.